Coronavirus vaccine maker Pfizer said that its vaccine is safe for younger children.
Pfizer conducted a study with a lower dose of its two-shot COVID-19 vaccine in more than 2,200 kindergartners and elementary school-aged kids, according to We Are Iowa.
As of now, vaccine from Pfizer and its German partner BioNtech is only available for people 12 years and older, according to We Are Iowa.
The trial showed that the vaccine was safe and created a “robust” antibody response in the 5- to 11-year-old children that participated in the study, Pfizer said, according to CNN.
"Pfizer being touted as good for children aged 5-11. It’s time," Twitter user Enyawd_da_Great said in a tweet.
No instances of heart inflammation or myocarditis were reported according to a Pfizer spokesperson, CNN reported.
The heart condition has been linked to the messenger RNA, or mRNA, vaccines.
According to CNN, Pfizer is expecting data in a trial for children as young as 6 months "as soon as the fourth quarter of this year."
A former Food and Drug Administration commissioner and current Pfizer board member Dr. Scott Gottlieb said that a vaccine for younger children, ages 5 to 11, could possibly be available by Halloween, according to CNN.
Alerts Sign-up